NP0332296 | Violaceotide C | | | C23H34N4O5
446.5480 Da 446.25292 Da | |
NP0332297 | Violaceotide D | | | C24H36N4O6
476.5740 Da 476.26348 Da | |
NP0332298 | Violaceotide B | | | C25H36N4O6
488.5850 Da 488.26348 Da | |
NP0332299 | asterripeptide C | | | C28H31N3O4
473.5730 Da 473.23146 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0332300 | asterresin A | | | C24H20N2O5
416.4330 Da 416.13722 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0332301 | terreuside A | | | C39H40N2O8
664.7550 Da 664.27847 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0332302 | asterripeptide A | | | C29H33N3O4
487.6000 Da 487.24711 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0332303 | terreuside B | | | C42H48N2O8
708.8520 Da 708.34107 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0332304 | giluterrin | | | C29H28N2O5
484.5520 Da 484.19982 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0332305 | asterripeptide B | | | C29H33N3O4
487.6000 Da 487.24711 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0332306 | tetrapetalone G | | | C20H23NO5
357.4060 Da 357.15762 Da | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) |
|
NP0332307 | tetrapetalone K | | | C24H29NO7
443.4960 Da 443.19440 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) |
|
NP0332308 | tetrapetalone E | | | C25H31NO9
489.5210 Da 489.19988 Da | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) |
|
NP0332309 | tetrapetalone H | | | C26H33NO9
503.5480 Da 503.21553 Da | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) |
|
NP0332310 | tetrapetalone F | | | C19H21NO5
343.3790 Da 343.14197 Da | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) |
|
NP0332311 | tetrapetalone I | | | C25H31NO7
457.5230 Da 457.21005 Da | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) |
|
NP0332312 | tetrapetalone J | | | C25H31NO8
473.5220 Da 473.20497 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) |
|
NP0332313 | Glycosyl-migrastatin | | | C33H49NO12
651.7500 Da 651.32548 Da | |
NP0332314 | 5-Hydroxy-migrastatin | | | C27H39NO8
505.6080 Da 505.26757 Da | |
NP0332315 | (-)-(7S,8R,1’R,3’R,4’R,5’S)-delta8’-4’-acetoxy-,5,3’,5’-trimethoxy-3,4-methylenedioxy-1’,2’,3’,4,’5’,6’-hexahydro-6’-oxo-7.3’,8.5’-neolignan | | | C24H30O8
446.4960 Da 446.19407 Da | [1H, 13C] NMR Spectrum (2D, 300 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 75 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 300 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 300 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 75 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 300 MHz, CDCl3, experimental) |
|
NP0332316 | (+)-(7S,8R,1’R,3’R,5’R,6’S)-delta8’-6’-hydroxy-3,4,5,3’,5’-pentamethoxy-1’,2’,3’,4,’5’,6’-hexahydro-4’-oxo-7.3’,8.5’-neolignan | | | C23H32O7
420.5020 Da 420.21480 Da | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) |
|
NP0332317 | (-)-(7S,8R,3’R,4’S,5’S)-delta8’-4’-acetoxy-3,4,5,3’,5’-pentamethoxy-2’,3’,4’,5’-tetrahydro-2’-oxo-7.3’,8.5’-neolignan | | | C25H32O8
460.5230 Da 460.20972 Da | [1H, 13C] NMR Spectrum (2D, 300 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 75 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 300 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 300 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 300 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 75 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 300 MHz, CDCl3, experimental) |
|
NP0332318 | (-)-(7S,8R,3’R,4’R,5’S)-delta8’-4’-hydroxy-5,3’,5’-trimethoxy-3,4-methylenedioxy-3’,4,’5’,6’-tetrahydro-6’-oxo-7.3’,8.5’-neolignan | | | C22H26O7
402.4430 Da 402.16785 Da | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 75 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 300 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) |
|
NP0332319 | (-)-(7S,8R,1’R,3’R,4’R,5’R,6’S)-delta8’-4’-acetoxy-6’-hydroxy-5,3’,5’-trimethoxy-3,4-methylenedioxy-1’,2’,3’,4,’5’,6’-hexahydro-7.3’,8.5’-neolignan | | | C24H32O8
448.5120 Da 448.20972 Da | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 75 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 300 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 75 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) |
|
NP0332320 | (-)-(7S,8R,1’S,3’R,4’R,5’S)-4’-acetoxy-1’,9’-dihydroxy-5,3’,5’-trimethoxy-3,4-methylenedioxy-1’,2’,3’,4,’5’,6’-hexahydro-6’,8’-dioxo-7.3’,8.5’-neolignan | | | C24H30O11
494.4930 Da 494.17881 Da | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 75 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 300 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) |
|